Status:
COMPLETED
Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers
Lead Sponsor:
University of Ioannina
Conditions:
Post-ERCP Acute Pancreatitis
Eligibility:
All Genders
18+ years
Brief Summary
Octreotide, somatostatin and pentoxyfilline commercially available drugs that are used in various clinical situations. They are safe and known for years. Octreotide and somatostatin have been used in ...
Eligibility Criteria
Inclusion
- patients undergoing endoscopic retrograde cholangiopancreatography
Exclusion
- children, pregnant or breastfeeding women
- patients with coagulation disorders
- inability to access the papilla of Vater due to technical difficulties (previous surgery, malignant obstruction)
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
End Date :
September 1 2006
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00222092
Start Date
September 1 2005
End Date
September 1 2006
Last Update
August 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hepato-Gastroenterology Unit, Medical School of Ioannina - Greece
Ioannina, Greece, 45110